Trends in Colorectal Cancer Incidence Associated with Reduced Physical Activity in China from 1990 to 2021

• by Qian Yang, Yao Hu, Fang Liu

• November 26, 2025

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

A Meta-Analysis on the Effectiveness and Safety of FOLFOX Plus Bevacizumab for Colorectal Cancer Treatment

• by Ma, Weiyin , Song, Zhengming , Zhu, Yuandong

• May 5, 2026

Comparative molecular analysis of colorectal cancer in Saudi Arabia: distinct genetic alterations and clinical features

• by Maha-Hamadien Abdulla, Jumanah Yousef Alshenaifi, Mansoor-Ali Vaali-Mohammed, Ahmad Zubaidi, Khayal Al Khayal, Noura S. Alhassan, Khalid Abdulrahman Al-Saleh, Omar Al Obeed, Scott Kopetz

• May 1, 2026